Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Head and Neck Pathology
Published in: Head and Neck Pathology 4/2018

01-12-2018 | Original Paper

Clinicopathological and Immunohistochemical Study of Head and Neck Langerhans Cell Histiocytosis from Latin America

Authors: Natália Rocha Bedran, Román Carlos, Bruno Augusto Benevenuto de Andrade, Ana Paula Silva Bueno, Mário José Romañach, Cristiane Bedran Milito

Published in: Head and Neck Pathology | Issue 4/2018

Login to get access

Abstract

Langerhans cell histiocytosis (LCH) is an inflammatory myeloid neoplastic proliferation with variable clinical behavior caused by the accumulation of CD1a+/CD207+ histiocytes, associated with a variable number of eosinophils, lymphocytes, plasma cells and multinucleated giant cells, most commonly observed in male children. LCH is uncommon in the head and neck region, occurring as ulcerated and reddened plaques or nodules that cause destruction of adjacent soft tissues and bone. The exact etiology of LCH is still unknown and controversial, with possible etiologic role of viruses, including Epstein–Barr virus (EBV). The aim of this study was to describe the clinicopathologic and immunohistochemical features of patients with LCH of the head and neck region. Clinical data from 19 patients with LCH were obtained from the archives of the Federal University of Rio de Janeiro and the Clinical Head and Neck Center of Guatemala. All cases were submitted to morphological, immunohistochemical analysis with CD1a, CD207, CD3, CD20, CD68, S-100 and Ki-67 and in situ hybridization for EBV. Ten cases were female and 9 male, with mean age of 11.5 years. Fourteen cases were located in the oral cavity, three cases in lymph nodes, and two cases in the scalp. In regard to the oral lesions, 13 cases were intra-osseous with six cases in anterior mandible, five cases in posterior mandible, and two cases in posterior maxilla while one case was located exclusively in the gingiva. The inflammatory pattern showed variation in the number of plasma cells, eosinophils and lymphocytes, while tumor cells were positive for CD1a, S-100 and CD68 in all cases, and positive for CD207 in 18 cases. In situ hybridization for EBV were negative in all cases.

Literature
  1. Pileri SA, Feldman AL, Cheuk W, Slater L. Langerhans cell histiocytosis. In: El-Nagar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ, editors. WHO classification of head and neck tumours. 4th ed. Lyon: IARC; 2017. pp. 130–1.
  2. Hicks J, Flaitz. Langerhans cell histiocytosis: current insights in a molecular age with emphasis on clinical oral and maxillofacial pathology practice. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005;100:S42–66.View Article
  3. Madrigal-Martínez-Pereda C, Guerrero-Rodríguez V, Guisado-Moya B, Meniz-García C. Langerhans cell histiocytosis: literature review and descriptive analysis of oral manifestations. Med Oral Patol Oral Cir Bucal. 2009;14(5):E222–8.
  4. Berres ML, Merad M, Allen CE. Progress in understanding the pathogenesis of Langerhans cell histiocytosis: back to Histiocytosis X? Br J Haematol. 2015;169:3–13.View Article
  5. Baumgartner I, von Hochstetter A, Baumert B, Luetolf U, Follath F. Langerhans’-cell histiocytosis in adults. Med Pediatr Oncol. 1997;28:9–14.View Article
  6. David R, Oria RA, Kumar R, Singleton EB, Lindell MM, Shirkhoda A, Madewell JE. Radiologic features of eosinophilic granuloma of bone. MR Am J Roentgenol. 1989;153:1021.View Article
  7. Hernández-Juyol M, Boj-Quesada JR, Gallego Melcon S. Oral manifestations of Langerhans cell histiocytosis. Case study of a two year-old boy. Med Oral. 2003;8:19–25.
  8. Mínguez I, Mínguez JM, Bonet J, Peñarrocha M, Sanchis JM. Oral manifestations of chronic disseminated histiocytosis. A report of 10 cases. Med Oral. 2004;9:149–54.
  9. Lewoczko KB, Rohman GT, LeSueur JR, Stocks RM, Thompson JW. Head and neck manifestations of langerhan’s cell histiocytosis in children: a 46-year experience. Int J Pediatr Otorhinolaryngol. 2014;78:1874–6.View Article
  10. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J. WHO classification of tumors of hematopoietic and lymphoid tissues. 2017; p. 359.
  11. Querings K, Starz H, Balda BR. Clinical spectrum of cutaneous Langerhans’ cell histiocytosis mimicking various diseases. Acta Derm Venereol. 2006;86:39–43.
  12. Chen CJ, Ho TY, Lu JJ, Sheu LF, Lee SY, Tien CH, et al. Identical twin brothers concordant for Langerhans’ cell histiocytosis and discordant for Epstein–Barr virus-associated hemophagocytic syndrome. Eur J Pediatr. 2004;163:536–9.
  13. Sakata N, Toguchi N, Kimura M, Nakayama M, Kawa K, Takemura T. Development of Langerhans cell histiocytosis associated with chronic active Epstein–Barr virus infection. Pediatr Blood Cancer. 2008;50:924–7.View Article
  14. Ashraf MJ, Makarempour A, Monabati A, Azarpira N, Khademi B, Hakimzadeh A. Comparison between presence of epstein barr virus in nodal and extra nodal diffuse large B cell lymphoma of head and neck, an Iranian experience. Iran Red Crescent Med J. 2012;14:764–70.View Article
  15. Shimakage M, Sasagawa T, Kimura M, Shimakage T, Seto S, Kodama K, et al. Expression of Epstein–Barr virus in Langerhans’ cell histiocytosis. Hum Pathol. 2004;35:862–8.View Article
  16. Purtilo DT. Epstein–Barr-virus-induced oncogenesis in immunedeficient individuals. Lancet. 1980;1:300–3.View Article
  17. Young LS, Rickinson AB. Epstein–Barr virus: 40 years on. Nat Rev Cancer. 2004;4:757–68.View Article
  18. Jeziorski E, Senechal B, Molina TJ, Devez F, Leruez-Ville M, Morand P. Herpes-virus infection in patients with Langerhans cell histiocytosis: a case-controlled sero-epidemiological study, and in situ analysis. PLoS ONE. 2008;3:e3262.View Article
  19. McClain K, Jin H, Gresik V, Favara B. Langerhans cell histiocytosis: lack of a viral etiology. Am J Hematol. 1994;47:16–20.View Article
  20. Schenka AA, De Angelo Andrade LA, Amstalden EM, Cintra ML, Vassallo J, Cardinalli IA, et al. Langerhans cell histiocytosis and its relationship with Epstein–Barr virus. Hum Pathol. 2006;37:1508–9.View Article
  21. Brousset P. Epstein–Barr virus and Langerhans cell histiocytosis. Hum Pathol. 2004;35:1573–4.View Article
  22. Panis V, Nikitakis N, Deskalopoulos A, Maragkou T, Tsiklakis K, Skavouvou A. Langerhans cell histiocytosis mimicking aggressive periodontitis: challenges in diagnosis and management. Quintessence Int. 2016;47:731–8.
  23. Facciolo MT, Riva F, Gallenzi P, Patini R, Gaglioti D. A rare case of oral multisystem Langerhans cell histiocytosis. J Clin Exp Dent. 2017;9:e820–4.
  24. Guimarães LF, Dias PFBPD., Janini ME, Souza IPR. Langerhans cell histiocytosis: impact on the permanent dentition after an 8-year follow-up. J Dent Child. 2008;75:64–8.
  25. Buchmann L, Emami A, Wei JL. Primary head and neck Langerhans cell histiocytosis in children. Otolaryngology 2006;135:312–7.View Article
  26. Eckardt A, Schultze A. Maxillofacial manifestations of Langerhans cell histiocytosis: a clinical and therapeutic analysis of 10 patients. Oral Oncol. 2003;39:687–94.View Article
  27. Murray M, Dean J, Slater L. Multifocal oral langerhans cell histiocytosis. J Oral Maxillofac Surg. 2011;69:2585–91.View Article
  28. Dagenais M, Pharoah MJ, Sikorski PA. The radiographic characteristics of histiocytosis X. A study of 29 cases that involve the jaws. Oral Surg Oral Med Oral Pathol. 1992;74:230–6.View Article
  29. Nicollas R, Rome A, Belaïch H, Roman S, Volk M, Gentet JC, Michel G, Triglia JM. Head and neck manifestation and prognosis of Langerhans’ cell histiocytosis in children. Int J Pediatr Otorhinolaryngol. 2010;74:669–73.View Article
  30. Saliba I, Sidani K, El Fata F, Arcand P, Quintal MC, Abela A. Langerhans’ cell histiocytosis of the temporal bone in children. Int J Pediatr Otorhinolaryngol. 2008;72:775–86.View Article
  31. Yashoda-Devi B, Rakesh N, Agarwal M. Langerhans cell histiocytosis with oral manifestations: a rare and unusual case report. J Clin Exp Dent. 2012;4:e252–5.View Article
  32. Pacino GA, Serrat A, Redondo LM, Verrier A. Langerhans cell histiocytosis: clinical diagnostic features and current concepts. Med Oral. 1999;4:607–18.
  33. Duncan WK, Post AC, McCoy BP. Eosinophilic granuloma. Oral Surg Oral Med Oral Pathol. 1988;65:736–41.View Article
  34. Baumgartner I, von Hochstetter A, Baumert B, Luetolf U, Follath F. Langerhans’-cell histiocytosis in adults. Med Pediatr Oncol. 1997;28(1):9–14.View Article
  35. Stålemark H, Laurencikas E, Karis J, Gavhed D, Fadeel B, Henter J. Incidence of Langerhans cell histiocytosis in children: a population-based study. Pediatr Blood Cancer. 2008;51:76e81.View Article
  36. Hashimoto K, Pritzker MS. Electron microscopic study of reticulohistiocytoma: an unusual case of congenital, self-healing reticulohistiocytosis. Arch Dermatol. 1973;107:263–70.View Article
  37. Longaker MA, Frieden IJ, LeBoit PE, Sherertz EF. Congenital ‘‘self-healing’’ Langerhans cell histiocytosis: the need for long-term follow-up. J Am Acad Dermatol. 1994;31:910–6.View Article
  38. Larralde M, Rositto A, Giardelli M, Gatti CF, Munoz AS. Congenital self-healing histiocytosis (Hashimoto-Pritzker). Int J Dermatol. 1999;38:693–6.View Article
  39. Jang KA, Ahn SJ, Choi JH, Sung KJ, Moon KC, Koh JK. Histiocytic disorders with pontaneous regression in infancy. Pediatr Dermatol. 2000;17:364–8.View Article
  40. Geissmann F, Emile JF, Andry R, Thomas C, Fraitag S, De Prost Y, et al. Lack of expression of E-cadherin is associated with dissemination of Langerhans cell histiocytosis and poor outcome. J Pathol. 1997;181:301–4.View Article
  41. Stein SL, Paller AS, Haut PR, Mancini AJ. Langerhans cell histiocytosis presenting in the neonatal period: a retrospective case series. Arch Pediatr Adolesc Med. 2001;155:778–83.View Article
  42. Merglová V, Hrusák D, Boudová L, Mukensnabl P, Valentová E, Hosticka L. Langerhans cell histiocytosis in childhood—review, symptoms in the oral cavity, differential diagnosis and report of two cases. J Craniomaxillofac Surg. 2014;42:93–100.View Article
  43. Haupt R, Minkov M, Astigarraga I, Schäfer E, Nanduri V, Jubran R, et al. Langerhans cell histiocytosis (LCH): guidelines for diagnosis, clinical work-up, and treatment for patients till the age of 18 years. Pediatr Blood Cancer. 2013;60:175–84.View Article
  44. Emile JF, Abla O, Fraitag S, Horne A, Haroche J, Donadieu J, et al. Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages. Blood. 2016;127:2672–81.View Article
  45. Ducassou S, Seyrig F, Thomas C, Lambilliotte A, Marec-Berard P, Berger C, et al. Thymus and mediastinal node involvement in childhood Langerhans ceel histiocytosis: long-term follow-up from the French national cohort. Pediatr Blood Cancer. 2013;60:1759e65.
  46. Hage C, Willman CL, Favara BE, Isaacson PG. Langerhans’ cell histiocytosis (histiocytosis): immunophenotype and growth fraction. Hum Pathol. 1993;24:840–5.View Article
  47. Bank MI, Rengtved P, Carstensen H, Petersen BL. Langerhans cell histiocytosis: an evaluation of histopathological parameters, demonstration of proliferation by Ki-67 and mitotic bodies. APMIS 2003;111:300–8.View Article
  48. Lau SK, Chu PG, Weiss LM. Immunohistochemical expression of Langerin in Langerhans cell histiocytosis and non-Langerhans cell histiocytic disorders. Am J Surg Pathol. 2008;32:615–9.View Article
  49. Sahm F, Capper D, Preusser M, Meyer J, Stenzinger A, Lasitschka F, Berghoff AS, Habel A, Schneider M, Kulozik A, Anagnostopoulos I, Mullauer L, Mechtersheimer G, von Deimling A. BRAFV600E mutant protein is expressed in cells of variable maturation in Langerhans cell histiocytosis. Blood. 2012;120:e28–34.View Article
  50. Varga E, Korom I, Polyánka H, Szabó K, Széll M, Baltás E, Bata-Csörgő Z, Kemény L, Oláh J. BRAFV600E mutation in cutaneous lesions of patients with adult Langerhans cell histiocytosis. J Eur Acad Dermatol Venereol. 2015;29:1205–11.View Article
  51. Kilpatrick SE, Wenger DE, Gilchrist GS, et al. Langerhans’ cell histiocytosis (histiocytosis X) of bone. A clinicopathologic analysis of 263 pediatric and adult cases. Cancer 1995;76(12):2471–84.View Article
  52. Monsereenusorn C, Rodriguez-Galindo C. Clinical characteristics and treatment of langerhans cell histiocytosis. Hematol Oncol Clin N Am. 2015;29:853–73.View Article
Metadata
Title
Clinicopathological and Immunohistochemical Study of Head and Neck Langerhans Cell Histiocytosis from Latin America
Authors
Natália Rocha Bedran
Román Carlos
Bruno Augusto Benevenuto de Andrade
Ana Paula Silva Bueno
Mário José Romañach
Cristiane Bedran Milito
Publication date
01-12-2018
Publisher
Springer US
Published in
Head and Neck Pathology / Issue 4/2018
Electronic ISSN: 1936-0568
DOI
https://doi.org/10.1007/s12105-017-0867-1

Other articles of this Issue 4/2018

Head and Neck Pathology 4/2018 Go to the issue

Original Paper

Expression and Significance of Cytokeratin 7, a Squamocolumnar Junction Marker, in Head and Neck Squamous Cell Carcinoma

Sine qua non Radiology-Pathology

Juvenile Trabecular Ossifying Fibroma

Original Paper

Systemic Non-Hodgkin T Cell Lymphomas Presenting in the Head and Neck Region: An Institutional Experience of a Rare Entity

Case Report

Microcystic Calcifying Epithelial Odontogenic Tumor

Original Paper

Dermatologic Lesions Submitted to an Oral and Maxillofacial Pathology Biopsy Service: An Analysis of 2487 Cases

Case Report

A Case of Concomitant Pemphigus Foliaceus and Oral Pemphigus Vulgaris